Status: Recruiting
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
LEAH is a prospective, observational, single-centre, non-randomised, open-label study of people at increased risk of cancer or malignant disease. The main objective of LEAH is to evaluate and compare the sensitivity of different tests on body fluids to detect cancers that will occur within 3 years of inclusion in the study, in a cohort of individuals identified as being at increased risk of cancer.
Participants needed: 5,909
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Gustave Roussy, Cancer Campus, Grand ParisUpdated: Mar 30, 2026Locations: 1
Eligibility criteria
Are aged 18 or more [+75]
Known prior diagnosis of cancer or hematological malignancy within the past 5 ye... [+7]